Smart Innovation

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible. 
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities. 

AMR Insights is for:

  • Researchers at Universities and University Medical Centers
  • Researchers at Research Institutes
  • R&D professionals in Pharma, Biopharma and Diagnostics companies
  • Entrepreneurs in start-up’s and spin off companies
  • Innovators, Venture Capitalists.

Latest Topics

  •   01 May 2024

    Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria

    The development of a unique antibiotic class targeting lipopolysaccharide synthesis, a clinically unexploited target in Gram-negative bacteria, has been identified. The compounds target the lipopolysaccharide synthesis pathway, which is essential in most Gram-negative bacteria. The compounds have potent in vivo efficacy against bloodstream infections caused by E. coli and Klebsiella pneumoniae. The series has favorable […]

    Read more...
  •   01 May 2024

    In vitro model at centre of antimicrobial drug development

    The Antimicrobial Resistance (AMR) crisis is putting the existing antibiotic arsenal under increasing threat, and researchers are exploring innovative ways to get new drugs to the market. The in vitro Hollow Fibre Infection Model (HFIM) plays a crucial role in this process, helping characterize new drugs and drug combinations and pushing them through clinical trials […]

    Read more...
  •   27 April 2024

    Navigating antimicrobial resistance in a globalized world: The crucial roles of the gut microbiome and migration

    Antimicrobial resistance (AMR) is a global health issue, affecting lifesaving antimicrobials. The human microbiome, a complex ecosystem of microbes, is a significant reservoir of AMR genes. The gut microbiota, a reservoir of ARGs, can be passed between different microbial species, leading to the spread of resistant microbes. Antimicrobial exposure disrupts the gut microbiome’s balance, promoting […]

    Read more...

More news related to Smart innovation

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed